Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13583
Country/Region: Mozambique
Year: 2018
Main Partner: Columbia University
Main Partner Program: Mailman School of Public Health
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $24,588,688 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,162,854
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $1,162,854
Care: Pediatric Care and Support (PDCS) $465,142
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $9,667,313
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $1,395,423
Sexual Prevention: Other Sexual Prevention (HVOP) $1,150,000
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $2,142,847
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $6,279,401
Treatment: Pediatric Treatment (PDTX) $1,162,854
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 37
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 13
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 73
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 19
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 37
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 11
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 37
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 14
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 80
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 23
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 192
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 59
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 17
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 7
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 17
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 6
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 149
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 46
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 188
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 54
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 222
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 65
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 265
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 72
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 74
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 23
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 111
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 27
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 74
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 23
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 111
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 27
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 74
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 23
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 111
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 27
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 868
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 267
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 759
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 233
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 1,085
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 346
GEND_GBV Number of people receiving post-GBV care 2019 1,882
GEND_GBV Number of people receiving post-GBV care 2019 644
HTS_TST <1, Unknown Sex, Negative 2019 3,988
HTS_TST <1, Unknown Sex, Negative 2019 3,788
HTS_TST 1-9, Unknown Sex, Negative 2019 25,443
HTS_TST 1-9, Unknown Sex, Negative 2019 24,222
HTS_TST 10-14, Female, Negative 2019 5,016
HTS_TST 10-14, Female, Negative 2019 4,779
HTS_TST 10-14, Male, Negative 2019 4,422
HTS_TST 10-14, Male, Negative 2019 4,211
HTS_TST 15-19, Female, Negative 2019 10,791
HTS_TST 15-19, Female, Negative 2019 10,513
HTS_TST 15-19, Male, Negative 2019 5,366
HTS_TST 15-19, Male, Negative 2019 6,725
HTS_TST 20-24, Female, Negative 2019 35,411
HTS_TST 20-24, Female, Negative 2019 26,168
HTS_TST 20-24, Male, Negative 2019 14,210
HTS_TST 20-24, Male, Negative 2019 15,212
HTS_TST 25-29, Female, Negative 2019 16,667
HTS_TST 25-29, Female, Negative 2019 4,716
HTS_TST 25-29, Female, Negative 2019 620
HTS_TST 25-29, Female, Negative 2019 19,203
HTS_TST 25-29, Female, Negative 2019 15,588
HTS_TST 25-29, Female, Negative 2019 330
HTS_TST 25-29, Female, Negative 2019 1,747
HTS_TST 25-29, Female, Negative 2019 4,614
HTS_TST 25-29, Female, Negative 2019 246
HTS_TST 25-29, Female, Negative 2019 25,233
HTS_TST 25-29, Female, Negative 2019 517
HTS_TST 25-29, Female, Negative 2019 2,307
HTS_TST 25-29, Male, Negative 2019 14,211
HTS_TST 25-29, Male, Negative 2019 4,011
HTS_TST 25-29, Male, Negative 2019 730
HTS_TST 25-29, Male, Negative 2019 10,720
HTS_TST 25-29, Male, Negative 2019 541
HTS_TST 25-29, Male, Negative 2019 2,569
HTS_TST 25-29, Male, Negative 2019 2,725
HTS_TST 25-29, Male, Negative 2019 225
HTS_TST 25-29, Male, Negative 2019 675
HTS_TST 25-29, Male, Negative 2019 2,277
HTS_TST 25-29, Male, Negative 2019 10,993
HTS_TST 30-34, Female, Negative 2019 16,667
HTS_TST 30-34, Female, Negative 2019 4,716
HTS_TST 30-34, Female, Negative 2019 620
HTS_TST 30-34, Female, Negative 2019 19,203
HTS_TST 30-34, Female, Negative 2019 15,472
HTS_TST 30-34, Female, Negative 2019 330
HTS_TST 30-34, Female, Negative 2019 1,747
HTS_TST 30-34, Female, Negative 2019 4,614
HTS_TST 30-34, Female, Negative 2019 246
HTS_TST 30-34, Female, Negative 2019 25,233
HTS_TST 30-34, Female, Negative 2019 517
HTS_TST 30-34, Female, Negative 2019 2,307
HTS_TST 30-34, Male, Negative 2019 14,211
HTS_TST 30-34, Male, Negative 2019 4,011
HTS_TST 30-34, Male, Negative 2019 730
HTS_TST 30-34, Male, Negative 2019 10,720
HTS_TST 30-34, Male, Negative 2019 541
HTS_TST 30-34, Male, Negative 2019 2,569
HTS_TST 30-34, Male, Negative 2019 2,725
HTS_TST 30-34, Male, Negative 2019 225
HTS_TST 30-34, Male, Negative 2019 675
HTS_TST 30-34, Male, Negative 2019 2,277
HTS_TST 30-34, Male, Negative 2019 10,993
HTS_TST 35-39, Female, Negative 2019 16,667
HTS_TST 35-39, Female, Negative 2019 4,716
HTS_TST 35-39, Female, Negative 2019 620
HTS_TST 35-39, Female, Negative 2019 19,203
HTS_TST 35-39, Female, Negative 2019 15,495
HTS_TST 35-39, Female, Negative 2019 330
HTS_TST 35-39, Female, Negative 2019 1,747
HTS_TST 35-39, Female, Negative 2019 4,614
HTS_TST 35-39, Female, Negative 2019 246
HTS_TST 35-39, Female, Negative 2019 25,233
HTS_TST 35-39, Female, Negative 2019 517
HTS_TST 35-39, Female, Negative 2019 2,307
HTS_TST 35-39, Male, Negative 2019 14,211
HTS_TST 35-39, Male, Negative 2019 4,011
HTS_TST 35-39, Male, Negative 2019 730
HTS_TST 35-39, Male, Negative 2019 10,627
HTS_TST 35-39, Male, Negative 2019 541
HTS_TST 35-39, Male, Negative 2019 2,569
HTS_TST 35-39, Male, Negative 2019 2,725
HTS_TST 35-39, Male, Negative 2019 225
HTS_TST 35-39, Male, Negative 2019 675
HTS_TST 35-39, Male, Negative 2019 2,277
HTS_TST 35-39, Male, Negative 2019 10,993
HTS_TST 40-49, Female, Negative 2019 16,667
HTS_TST 40-49, Female, Negative 2019 4,716
HTS_TST 40-49, Female, Negative 2019 620
HTS_TST 40-49, Female, Negative 2019 19,203
HTS_TST 40-49, Female, Negative 2019 15,495
HTS_TST 40-49, Female, Negative 2019 330
HTS_TST 40-49, Female, Negative 2019 1,747
HTS_TST 40-49, Female, Negative 2019 4,614
HTS_TST 40-49, Female, Negative 2019 246
HTS_TST 40-49, Female, Negative 2019 25,233
HTS_TST 40-49, Female, Negative 2019 517
HTS_TST 40-49, Female, Negative 2019 2,307
HTS_TST 40-49, Male, Negative 2019 14,211
HTS_TST 40-49, Male, Negative 2019 4,011
HTS_TST 40-49, Male, Negative 2019 730
HTS_TST 40-49, Male, Negative 2019 10,743
HTS_TST 40-49, Male, Negative 2019 541
HTS_TST 40-49, Male, Negative 2019 2,569
HTS_TST 40-49, Male, Negative 2019 2,725
HTS_TST 40-49, Male, Negative 2019 225
HTS_TST 40-49, Male, Negative 2019 675
HTS_TST 40-49, Male, Negative 2019 2,277
HTS_TST 40-49, Male, Negative 2019 10,993
HTS_TST 50+, Female, Negative 2019 6,310
HTS_TST 50+, Female, Negative 2019 6,972
HTS_TST 50+, Male, Negative 2019 7,384
HTS_TST 50+, Male, Negative 2019 5,392
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 530,767
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 611,702
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 31,382
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 28,513
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 75,215
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 54,183
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 22
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 5
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 784
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 936
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 4,999
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 5,968
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 980
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 1,174
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 863
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 1,040
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 2,783
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 3,045
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 1,372
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 1,471
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 7,404
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 10,009
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 4,123
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 4,032
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 1,747
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 1,840
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 1,481
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 2,120
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 405
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 221
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 1,964
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 3,614
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 425
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 232
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 398
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 216
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 199
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 94
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 289
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 47
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 801
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 530
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 386
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 53
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 402
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 407
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 535
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 25
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 1,665
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 837
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 104
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 112
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 45
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 3
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 476
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 279
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 259
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 287
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 601
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 397
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 558
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 346
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 67
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 117
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 682
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 1,105
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 340
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 208
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 253
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 157
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 1,955
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 601
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 595
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 377
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 3,840
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 3,706
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 1,782
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 2,286
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 794
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 880
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 910
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 1,103
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 9,881
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 9,512
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2019 1,500
HTS_TST_POS <1, Unknown Sex, Positive 2019 49
HTS_TST_POS <1, Unknown Sex, Positive 2019 97
HTS_TST_POS 1-9, Unknown Sex, Positive 2019 312
HTS_TST_POS 1-9, Unknown Sex, Positive 2019 599
HTS_TST_POS 10-14, Female, Positive 2019 60
HTS_TST_POS 10-14, Female, Positive 2019 115
HTS_TST_POS 10-14, Male, Positive 2019 54
HTS_TST_POS 10-14, Male, Positive 2019 105
HTS_TST_POS 15-19, Female, Positive 2019 466
HTS_TST_POS 15-19, Female, Positive 2019 538
HTS_TST_POS 15-19, Male, Positive 2019 231
HTS_TST_POS 15-19, Male, Positive 2019 348
HTS_TST_POS 20-24, Female, Positive 2019 1,532
HTS_TST_POS 20-24, Female, Positive 2019 1,412
HTS_TST_POS 20-24, Male, Positive 2019 614
HTS_TST_POS 20-24, Male, Positive 2019 825
HTS_TST_POS 25-29, Female, Positive 2019 724
HTS_TST_POS 25-29, Female, Positive 2019 186
HTS_TST_POS 25-29, Female, Positive 2019 58
HTS_TST_POS 25-29, Female, Positive 2019 326
HTS_TST_POS 25-29, Female, Positive 2019 946
HTS_TST_POS 25-29, Female, Positive 2019 20
HTS_TST_POS 25-29, Female, Positive 2019 122
HTS_TST_POS 25-29, Female, Positive 2019 266
HTS_TST_POS 25-29, Female, Positive 2019 28
HTS_TST_POS 25-29, Female, Positive 2019 757
HTS_TST_POS 25-29, Female, Positive 2019 42
HTS_TST_POS 25-29, Female, Positive 2019 305
HTS_TST_POS 25-29, Male, Positive 2019 616
HTS_TST_POS 25-29, Male, Positive 2019 161
HTS_TST_POS 25-29, Male, Positive 2019 39
HTS_TST_POS 25-29, Male, Positive 2019 670
HTS_TST_POS 25-29, Male, Positive 2019 35
HTS_TST_POS 25-29, Male, Positive 2019 140
HTS_TST_POS 25-29, Male, Positive 2019 163
HTS_TST_POS 25-29, Male, Positive 2019 32
HTS_TST_POS 25-29, Male, Positive 2019 55
HTS_TST_POS 25-29, Male, Positive 2019 293
HTS_TST_POS 25-29, Male, Positive 2019 115
HTS_TST_POS 30-34, Female, Positive 2019 724
HTS_TST_POS 30-34, Female, Positive 2019 186
HTS_TST_POS 30-34, Female, Positive 2019 58
HTS_TST_POS 30-34, Female, Positive 2019 326
HTS_TST_POS 30-34, Female, Positive 2019 966
HTS_TST_POS 30-34, Female, Positive 2019 20
HTS_TST_POS 30-34, Female, Positive 2019 122
HTS_TST_POS 30-34, Female, Positive 2019 266
HTS_TST_POS 30-34, Female, Positive 2019 28
HTS_TST_POS 30-34, Female, Positive 2019 757
HTS_TST_POS 30-34, Female, Positive 2019 42
HTS_TST_POS 30-34, Female, Positive 2019 305
HTS_TST_POS 30-34, Male, Positive 2019 616
HTS_TST_POS 30-34, Male, Positive 2019 161
HTS_TST_POS 30-34, Male, Positive 2019 59
HTS_TST_POS 30-34, Male, Positive 2019 658
HTS_TST_POS 30-34, Male, Positive 2019 35
HTS_TST_POS 30-34, Male, Positive 2019 140
HTS_TST_POS 30-34, Male, Positive 2019 163
HTS_TST_POS 30-34, Male, Positive 2019 32
HTS_TST_POS 30-34, Male, Positive 2019 55
HTS_TST_POS 30-34, Male, Positive 2019 293
HTS_TST_POS 30-34, Male, Positive 2019 115
HTS_TST_POS 35-39, Female, Positive 2019 724
HTS_TST_POS 35-39, Female, Positive 2019 186
HTS_TST_POS 35-39, Female, Positive 2019 58
HTS_TST_POS 35-39, Female, Positive 2019 326
HTS_TST_POS 35-39, Female, Positive 2019 946
HTS_TST_POS 35-39, Female, Positive 2019 20
HTS_TST_POS 35-39, Female, Positive 2019 122
HTS_TST_POS 35-39, Female, Positive 2019 266
HTS_TST_POS 35-39, Female, Positive 2019 28
HTS_TST_POS 35-39, Female, Positive 2019 757
HTS_TST_POS 35-39, Female, Positive 2019 42
HTS_TST_POS 35-39, Female, Positive 2019 305
HTS_TST_POS 35-39, Male, Positive 2019 616
HTS_TST_POS 35-39, Male, Positive 2019 161
HTS_TST_POS 35-39, Male, Positive 2019 59
HTS_TST_POS 35-39, Male, Positive 2019 656
HTS_TST_POS 35-39, Male, Positive 2019 35
HTS_TST_POS 35-39, Male, Positive 2019 140
HTS_TST_POS 35-39, Male, Positive 2019 163
HTS_TST_POS 35-39, Male, Positive 2019 32
HTS_TST_POS 35-39, Male, Positive 2019 55
HTS_TST_POS 35-39, Male, Positive 2019 293
HTS_TST_POS 35-39, Male, Positive 2019 115
HTS_TST_POS 40-49, Female, Positive 2019 724
HTS_TST_POS 40-49, Female, Positive 2019 186
HTS_TST_POS 40-49, Female, Positive 2019 58
HTS_TST_POS 40-49, Female, Positive 2019 326
HTS_TST_POS 40-49, Female, Positive 2019 944
HTS_TST_POS 40-49, Female, Positive 2019 20
HTS_TST_POS 40-49, Female, Positive 2019 122
HTS_TST_POS 40-49, Female, Positive 2019 266
HTS_TST_POS 40-49, Female, Positive 2019 28
HTS_TST_POS 40-49, Female, Positive 2019 757
HTS_TST_POS 40-49, Female, Positive 2019 42
HTS_TST_POS 40-49, Female, Positive 2019 305
HTS_TST_POS 40-49, Male, Positive 2019 616
HTS_TST_POS 40-49, Male, Positive 2019 161
HTS_TST_POS 40-49, Male, Positive 2019 59
HTS_TST_POS 40-49, Male, Positive 2019 656
HTS_TST_POS 40-49, Male, Positive 2019 35
HTS_TST_POS 40-49, Male, Positive 2019 140
HTS_TST_POS 40-49, Male, Positive 2019 163
HTS_TST_POS 40-49, Male, Positive 2019 32
HTS_TST_POS 40-49, Male, Positive 2019 55
HTS_TST_POS 40-49, Male, Positive 2019 293
HTS_TST_POS 40-49, Male, Positive 2019 115
HTS_TST_POS 50+, Female, Positive 2019 270
HTS_TST_POS 50+, Female, Positive 2019 439
HTS_TST_POS 50+, Male, Positive 2019 319
HTS_TST_POS 50+, Male, Positive 2019 320
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 989
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 484
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 2,301
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 929
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 128
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 74
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 122
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 118
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 60
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 53
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 353
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 383
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 204
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 153
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 92
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 68
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 80
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 81
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 51
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 42
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 77
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 76
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 40
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 40
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 53
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 91
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 27
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 51
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 20
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 46
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 37
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 66
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 210
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 64
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 123
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 32
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 607
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 203
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 222
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 149
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 60
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 115
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 60
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 200
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2019 107
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 137
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2019 10
PMTCT_ART Already on ART at beginning of current pregnancy 2019 2,131
PMTCT_ART Already on ART at beginning of current pregnancy 2019 1,026
PMTCT_ART New on ART 2019 5,929
PMTCT_ART New on ART 2019 2,562
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 8,060
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 3,588
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 214,441
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 163,286
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 6,372
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 2,868
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 1,585
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 721
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 7,957
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 3,589
PMTCT_EID Sum of Infant Age disaggregates 2019 7,957
PMTCT_EID Sum of Infant Age disaggregates 2019 3,589
PMTCT_STAT 25-29, Female 2019 43,924
PMTCT_STAT 25-29, Female 2019 26,847
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 1,571
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 798
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 40,766
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 24,798
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 1,560
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 1,116
PMTCT_STAT 30-34, Female 2019 41,980
PMTCT_STAT 30-34, Female 2019 36,855
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 1,591
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 823
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 39,706
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 35,452
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 677
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 555
PMTCT_STAT 35-39, Female 2019 40,652
PMTCT_STAT 35-39, Female 2019 35,403
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 1,584
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 815
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 38,659
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 34,240
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 671
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 538
PMTCT_STAT 40-49, Female 2019 39,544
PMTCT_STAT 40-49, Female 2019 34,783
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 1,572
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 812
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 37,584
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 33,629
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 638
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 538
PMTCT_STAT By Age (Numerator): : 15-19 2019 11,516
PMTCT_STAT By Age (Numerator): 10-14 2019 843
PMTCT_STAT By Age (Numerator): 10-14 2019 846
PMTCT_STAT By Age (Numerator): 15-19 2019 19,191
PMTCT_STAT By Age (Numerator): 20-24 2019 28,141
PMTCT_STAT By Age (Numerator): 20-24 2019 16,335
PMTCT_STAT By known positives: 15-19 2019 135
PMTCT_STAT By known positives: 20-24 2019 531
PMTCT_STAT By new negatives: 10-14 2019 812
PMTCT_STAT By new negatives: 15-19 2019 10,898
PMTCT_STAT By new negatives: 20-24 2019 14,993
PMTCT_STAT By new positives: 15-19 2019 348
PMTCT_STAT By new positives: 20-24 2019 758
PMTCT_STAT By Number of known positives: 15-19 2019 200
PMTCT_STAT By Number of known positives: 20-24 2019 1,232
PMTCT_STAT By Number of new negative: 10-14 2019 787
PMTCT_STAT By Number of new negative: 15-19 2019 18,324
PMTCT_STAT By Number of new negative: 20-24 2019 25,748
PMTCT_STAT By Number of new positives: 10-14 2019 1
PMTCT_STAT By Number of new positives: 15-19 2019 415
PMTCT_STAT By Number of new positives: 20-24 2019 1,025
PMTCT_STAT Number of new ANC and L&D clients 2019 221,337
PMTCT_STAT Number of new ANC and L&D clients 2019 167,887
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 214,441
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 163,286
PMTCT_STAT_den 25-29, Female 2019 29,642
PMTCT_STAT_den 25-29, Female 2019 21,931
PMTCT_STAT_den 30-34, Female 2019 31,502
PMTCT_STAT_den 30-34, Female 2019 24,530
PMTCT_STAT_den 35-39, Female 2019 30,993
PMTCT_STAT_den 35-39, Female 2019 24,297
PMTCT_STAT_den 40-49, Female 2019 30,447
PMTCT_STAT_den 40-49, Female 2019 23,694
PMTCT_STAT_den By Age (Denominator): <15-19 2019 39,398
PMTCT_STAT_den By Age (Denominator): 10-14 2019 2,369
PMTCT_STAT_den By Age (Denominator): 10-14 2019 3,174
PMTCT_STAT_den By Age (Denominator): 15-19 2019 29,908
PMTCT_STAT_den By Age (Denominator): 20-24 2019 56,986
PMTCT_STAT_den By Age (Denominator): 20-24 2019 40,353
PrEP_NEW 25-29, Female 2019 373
PrEP_NEW 25-29, Male 2019 184
PrEP_NEW 30-34, Female 2019 373
PrEP_NEW 30-34, Male 2019 184
PrEP_NEW 35-39, Female 2019 155
PrEP_NEW 35-39, Male 2019 39
PrEP_NEW Female 15-19 2019 373
PrEP_NEW Female 20-24 2019 373
PrEP_NEW FSW 2019 1,940
PrEP_NEW Male 15-19 2019 184
PrEP_NEW Male 20-24 2019 184
PrEP_NEW MSM 2019 485
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 2,425
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 37
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 10
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 642
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 305
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 42
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 17
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 795
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 318
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 1,557
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 696
TB_PREV By Age/Sex (Numerator): <15, Female 2019 446
TB_PREV By Age/Sex (Numerator): <15, Female 2019 305
TB_PREV By Age/Sex (Numerator): <15, Male 2019 393
TB_PREV By Age/Sex (Numerator): <15, Male 2019 265
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 10,805
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 7,338
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 5,963
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 4,049
TB_PREV IPT, Life-long ART, Already, Positive 2019 3,521
TB_PREV IPT, Life-long ART, Already, Positive 2019 2,394
TB_PREV IPT, Life-long ART, New, Positive 2019 14,083
TB_PREV IPT, Life-long ART, New, Positive 2019 9,562
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 17,604
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 11,956
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 23,467
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 15,938
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 603
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 414
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 551
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 375
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 14,146
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 9,605
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 8,165
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 5,544
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 4,695
TB_PREV_den IPT, Life-long ART, Already, Positive 2019 3,188
TB_PREV_den IPT, Life-long ART, New, Positive 2019 18,773
TB_PREV_den IPT, Life-long ART, New, Positive 2019 12,753
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 562
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 351
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 3,155
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 2,269
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 529
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 354
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 4,120
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 2,599
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 8,366
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 5,596
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 8,366
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 5,596
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 565
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 327
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 3,017
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 2,255
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 549
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 371
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 4,235
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 2,646
TX_CURR 25-29, Female, Positive 2019 9,599
TX_CURR 25-29, Female, Positive 2019 3,950
TX_CURR 25-29, Male, Positive 2019 5,030
TX_CURR 25-29, Male, Positive 2019 2,244
TX_CURR 30-34, Female, Positive 2019 9,598
TX_CURR 30-34, Female, Positive 2019 3,919
TX_CURR 30-34, Male, Positive 2019 5,030
TX_CURR 30-34, Male, Positive 2019 2,285
TX_CURR 35-39, Female, Positive 2019 9,610
TX_CURR 35-39, Female, Positive 2019 3,949
TX_CURR 35-39, Male, Positive 2019 5,027
TX_CURR 35-39, Male, Positive 2019 2,260
TX_CURR 40-49, Female, Positive 2019 9,610
TX_CURR 40-49, Female, Positive 2019 3,965
TX_CURR 40-49, Male, Positive 2019 5,023
TX_CURR 40-49, Male, Positive 2019 2,268
TX_CURR Age/Sex: <1 2019 703
TX_CURR Age/Sex: <1 2019 536
TX_CURR Age/Sex: <1-9 2019 4,761
TX_CURR Age/Sex: 1-9 2019 2,492
TX_CURR Age/Sex: 10-14 Female 2019 391
TX_CURR Age/Sex: 10-14 Female 2019 267
TX_CURR Age/Sex: 10-14 Male 2019 460
TX_CURR Age/Sex: 10-14 Male 2019 165
TX_CURR Age/Sex: 15-19 Female 2019 3,434
TX_CURR Age/Sex: 15-19 Female 2019 1,783
TX_CURR Age/Sex: 15-19 Male 2019 347
TX_CURR Age/Sex: 15-19 Male 2019 279
TX_CURR Age/Sex: 20-24 Female 2019 10,707
TX_CURR Age/Sex: 20-24 Female 2019 4,837
TX_CURR Age/Sex: 20-24 Male 2019 1,910
TX_CURR Age/Sex: 20-24 Male 2019 1,089
TX_CURR Age/Sex: 50+ Female 2019 4,897
TX_CURR Age/Sex: 50+ Female 2019 1,644
TX_CURR Age/Sex: 50+ Male 2019 4,118
TX_CURR Age/Sex: 50+ Male 2019 1,658
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 90,516
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 39,662
TX_CURR Sum of age/sex disaggregates 2019 3,781
TX_CURR Sum of Age/Sex disaggregations 2019 2,062
TX_NEW 25-29, Female, Positive 2019 1,475
TX_NEW 25-29, Female, Positive 2019 2,314
TX_NEW 25-29, Male, Positive 2019 1,056
TX_NEW 25-29, Male, Positive 2019 1,842
TX_NEW 30-34, Female, Positive 2019 1,478
TX_NEW 30-34, Female, Positive 2019 2,315
TX_NEW 30-34, Male, Positive 2019 1,058
TX_NEW 30-34, Male, Positive 2019 1,842
TX_NEW 35-39, Female, Positive 2019 1,478
TX_NEW 35-39, Female, Positive 2019 2,315
TX_NEW 35-39, Male, Positive 2019 1,838
TX_NEW 35-39, Male, Positive 2019 1,058
TX_NEW 40-49, Female, Positive 2019 2,307
TX_NEW 40-49, Female, Positive 2019 1,476
TX_NEW 40-49, Male, Positive 2019 1,832
TX_NEW 40-49, Male, Positive 2019 1,055
TX_NEW Breastfeeding status 2019 218
TX_NEW Breastfeeding status 2019 516
TX_NEW By Age/Sex: <1 2019 174
TX_NEW By Age/Sex: <1 2019 520
TX_NEW By Age/Sex: 1-9 2019 586
TX_NEW By Age/Sex: 1-9 2019 1,455
TX_NEW By Age/Sex: 10-14 Female 2019 75
TX_NEW By Age/Sex: 10-14 Female 2019 84
TX_NEW By Age/Sex: 10-14 Male 2019 54
TX_NEW By Age/Sex: 10-14 Male 2019 127
TX_NEW By Age/Sex: 15-19 Female 2019 1,091
TX_NEW By Age/Sex: 15-19 Female 2019 1,642
TX_NEW By Age/Sex: 15-19 Male 2019 213
TX_NEW By Age/Sex: 15-19 Male 2019 186
TX_NEW By Age/Sex: 20-24 Female 2019 2,425
TX_NEW By Age/Sex: 20-24 Female 2019 4,442
TX_NEW By Age/Sex: 20-24 Male 2019 958
TX_NEW By Age/Sex: 20-24 Male 2019 1,066
TX_NEW By Age/Sex: 50+ Female 2019 640
TX_NEW By Age/Sex: 50+ Female 2019 796
TX_NEW By Age/Sex: 50+ Male 2019 486
TX_NEW By Age/Sex: 50+ Male 2019 850
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 16,807
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 27,775
TX_NEW Pregnancy status 2019 3,932
TX_NEW Pregnancy status 2019 6,010
TX_NEW Sum of Age/Sex disaggregates 2019 5,942
TX_NEW Sum of Age/Sex disaggregates 2019 9,193
TX_PVLS <15, Undocumented Test Indication, Female 2019 2,609
TX_PVLS <15, Undocumented Test Indication, Female 2019 1,148
TX_PVLS <15, Undocumented Test Indication, Male 2019 1,822
TX_PVLS <15, Undocumented Test Indication, Male 2019 607
TX_PVLS 15+, Undocumented Test Indication, Female 2019 33,386
TX_PVLS 15+, Undocumented Test Indication, Female 2019 14,871
TX_PVLS 15+, Undocumented Test Indication, Male 2019 19,765
TX_PVLS 15+, Undocumented Test Indication, Male 2019 7,140
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 57,581
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 23,766
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 346
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 103
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 170
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 49
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 10,635
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 2,061
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 4,528
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 938
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 15,702
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 3,164
TX_RET Numerator by Status: Breastfeeding 2019 1,163
TX_RET Numerator by Status: Breastfeeding 2019 221
TX_RET Numerator by Status: Pregnant 2019 3,440
TX_RET Numerator by Status: Pregnant 2019 755
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 17,457
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 3,513
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 382
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 108
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 198
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 55
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 11,306
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 2,239
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 5,549
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 1,093
TX_RET_den Denominator by Status: Breastfeeding 2019 1,214
TX_RET_den Denominator by Status: Breastfeeding 2019 237
TX_RET_den Denominator by Status: Pregnant 2019 3,999
TX_RET_den Denominator by Status: Pregnant 2019 855
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 90,515
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 39,667
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 2,888
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 974
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 3,601
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 1,107
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2019 17,424
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2019 18,689
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 47,338
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 36,489
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 4,041
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 443
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 443
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 4,041
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 61,535
TX_TB_den Life-long ART, Already, TB Screen - Negative, Positive 2019 26,964
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 7,227
TX_TB_den Life-long ART, Already, TB Screen - Positive, Positive 2019 3,163
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 19,898
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 8,720
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 1,796
TX_TB_den Life-long ART, New, TB Screen - Positive, Positive 2019 784
VMMC_CIRC 30-34, Male 2019 797
VMMC_CIRC 35-39, Male 2019 797
VMMC_CIRC 40-49, Male 2019 1,594
VMMC_CIRC By Age: 10-14 2019 23,503
VMMC_CIRC By Age: 15-19 2019 19,305
VMMC_CIRC By Age: 20-24 2019 12,525
VMMC_CIRC By Age: 25-29 2019 6,879
VMMC_CIRC By Age: 50+ 2019 173
VMMC_CIRC By circumcision technique: Surgical VMMC 2019 65,568
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 65,568
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2019 62,385
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2019 55,506
Cross Cutting Budget Categories and Known Amounts Total: $4,823,460
Key Populations: MSM and TG $110,000
Training of health workers and community outreach workers
Key Populations: Sex Workers $110,000
Gender: Gender Based Violence (GBV) $272,200
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Post GBV Care
Food and Nutrition: Policy, Tools, and Service Delivery $230,050
Renovation $241,100
Condoms: Policy, Tools, and Services $300,000
Adolescent Girls and Young Women (AGYW) $287,500
Human Resources for Health $3,172,610
Motor Vehicles: Purchased $100,000